COVID-19 Antibody Treatment (REGEN-COV™)

IndyCare is offering antibody treatments for:

Treatment mild to moderate symptoms in HIGH RISK COVID-19 positive patients.

Post-exposure prevention in HIGH RISK persons who are not fully vaccinated or who are vaccinated but immunocompromised.

See HIGH RISK qualification criteria here.

What to expect

Treatment consists of 4 injections applied under the skin followed by 1 hour of observation.

Click the HIGH RISK criteria link above to see if you qualify for treatment.

Request an appointment below and IndyCare staff will contact you to schedule your treatment.

Review the the Fact Sheet for Patients, Parents and Caregivers/Emergency Use Authorization (EUA) of Monoclonal Antibodies for Coronavirus Disease 2019 (COVID-19) here.

Complete your online registration before your visit.

Park inside our Curbside Care Cove 5-10 mins before your appointment time.

We will come out to your vehicle and start your visit which will include a medical consultation, treatment and observation.

Treatment is covered by all major insurance. Check with your insurance plan to see if you have a copay or deductible. If you don’t have insurance we can apply to a program for uninsured that will cover the costs for you.

What are monoclonal antibodies (mAbs)?
Our bodies naturally make antibodies to fight infection. mAbs are made in a lab and given to people directly through an intravenous (IV) infusion or injection.
How do monoclonal antibodies help people with COVID-19?
mAb treatments authorized by the U.S. Food and Drug Administration (FDA) for emergency use may help people who are at high risk for serious symptoms of the disease to:● Reduce the likelihood of being hospitalized● Recover faster from COVID-19
Who can receive treatment?
mAbs are designed for people who● Have tested positive for COVID-19, and● Have mild to moderate symptoms of the disease for 10 days or less, and● Are at high risk of becoming seriously ill. ● Or high risk and exposed to someone who recently tested positive and not fully vaccinated.
How soon does someone need to start treatment?
mAb treatment must be given within 10 days of a person’s first symptoms of COVID-19. The sooner a person receives mAb treatment, the better.
Are monoclonal antibody treatments safe?
mAb treatments are experimental. However, they have received Emergency Use Authorization (EUA) from the FDA, and more than 400,000 people have been treated with mAbs. Researchers continue to study mAb treatments for safety and effectiveness. You can find more details from the FDA here.

What monoclonal antibody treatment does IndyCare offer?
At IndyCare we use the monoclonal antibody product REGEN-COV (casirivimab and imdevimab) and administer it subcutaneously.
Should I get the COVID-19 vaccine or booster if I have been treated with monoclonal antibodies?
If you were treated for COVID-19 with monoclonal antibodies you should wait 90 days before getting a COVID-19 vaccine or booster.
If I don’t qualify for mAb treatment but want help what can I do?
You should see a healthcare provider for treatment advise. There are some over-the-counter vitamins, supplements, and supportive care measures that may be helpful in managing your illness

*In case of a life-threatening emergency, immediately call 911.
**Information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment.
All content contained on or available through this site is for general information purposes only.
***By using this website and sending us your information, you are giving us permission to contact you by electronic and non-electronic means. We also track the conversions and collect user data to improve marketing.

Created by DearDoc

Website Privacy Policy

Accessibility Statement

Created by DearDoc

Website Privacy Policy

Accessibility Statement

COVID-19 Antibody Treatment (REGEN-COV™)

What are monoclonal antibodies (mAbs)?

Our bodies naturally make antibodies to fight infection. mAbs are made in a lab and given to people directly through an intravenous (IV) infusion or injection.

How do monoclonal antibodies help people with COVID-19?

mAb treatments authorized by the U.S. Food and Drug Administration (FDA) for emergency use may help people who are at high risk for serious symptoms of the disease to:● Reduce the likelihood of being hospitalized● Recover faster from COVID-19

Who can receive treatment?

mAbs are designed for people who● Have tested positive for COVID-19, and● Have mild to moderate symptoms of the disease for 10 days or less, and● Are at high risk of becoming seriously ill. ● Or high risk and exposed to someone who recently tested positive and not fully vaccinated.

How soon does someone need to start treatment?

mAb treatment must be given within 10 days of a person’s first symptoms of COVID-19. The sooner a person receives mAb treatment, the better.

Are monoclonal antibody treatments safe?

mAb treatments are experimental. However, they have received Emergency Use Authorization (EUA) from the FDA, and more than 400,000 people have been treated with mAbs. Researchers continue to study mAb treatments for safety and effectiveness. You can find more details from the FDA here.

What monoclonal antibody treatment does IndyCare offer?

At IndyCare we use the monoclonal antibody product REGEN-COV (casirivimab and imdevimab) and administer it subcutaneously.

Should I get the COVID-19 vaccine or booster if I have been treated with monoclonal antibodies?

If you were treated for COVID-19 with monoclonal antibodies you should wait 90 days before getting a COVID-19 vaccine or booster.

If I don’t qualify for mAb treatment but want help what can I do?

You should see a healthcare provider for treatment advise. There are some over-the-counter vitamins, supplements, and supportive care measures that may be helpful in managing your illness